MHUA - Gunggunge utang jangka dawa MeihuaMed

Logo grafis Meihua Medical Technologies (MHUA)

MeihuaMed (MHUA) produces medical technology for the global market, although trade wars and logistical disruptions in Asia could limit its growth. The linear price action on the GURU.Markets chart, where the indicator stands at 0.00, confirms the business's resilience to crises due to the demand for new developments. The company is currently optimizing costs and updating material compositions within the consumables segment.

MHUA Utang jangka dawa perusahaan Meihua Medical Technologies (28.04.2023 - 20.12.2025)

Meihua Medical Technologies Co., Ltd. - rincian analitis lan metrik utama (MHUA)

- rega saham lan prakiraan rega para ahli:
Kurs saham Meihua Medical Technologies|MHUA - Prakiraan konsensus analis
- statistik kapitalisasi pasar:
Kapitalisasi pasar MeihuaMed|MHUA - Nilai Perusahaan
- data ekuitas miturut neraca:
Nilai Akuntansi saben Saham MeihuaMed|MHUA - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku meihuamed.com|MHUA - Aset Agregat Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Utang marang Ekuitas MeihuaMed|MHUA - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Meihua Medical Technologies|MHUA - Gunggung utang perusahaan|Utang-utang marang aset resik MeihuaMed|MHUA - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan MeihuaMed|Koefisien jangkoan perantara meihuamed.com
- data bathi lan kelipatan valuasi:
MHUA - Penghasilan resik
Ringkesan analitik perusahaan:MHUA MeihuaMed
Produk sing diprodhuksi Meihua Medical

MeihuaMed (MHUA) is investing in environmental production upgrades and the implementation of ESG standards, which requires significant capital expenditures. This indicator aggregates all of the issuer's long-term liabilities, allowing for an assessment of debt sustainability relative to operating profit; analyzing the company's long-term debt chart helps investors determine how effectively borrowed capital is converted into strategic development and the reduction of its carbon footprint.

Pesaing MeihuaMed (MHUA)

ISRG: Tanggungan utang jangka dawa perusahaan|Danaher - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa BD BDX|STE: Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan West Pharma Corp|BAX (Baxter International) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan masimo.com|Utang jangka dawa perusahaan Stevanato Group (STVN)|Utang jangka dawa perusahaan TFX (Teleflex Inc.)|Merit Medical Systems Inc - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan NVST|ICU Medical, Inc. - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa dentsplysirona.com XRAY|LeMaitre Vascular (LMAT) - Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan ATRC|Utang jangka dawa perusahaan STAAR Surgical Corp|niagenbioscience.com (NAGE) - Gunggunge utang jangka dawa|Kewajiban jangka dawa perusahaan ZIMV (ZimVie Inc.)|Gedhene kewajiban jangka dawa ANGO|Utang jangka dawa perusahaan Cerus CERS|Silihan lan utang jangka dawa perusahaan TKNO|MGRM: Kewajiban jangka dawa perusahaan|STSS - Utang jangka dawa perusahaan|infusystem.com (INFU) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan utahmed.com|KRMD (KORU Medical Systems, Inc.) - Utang jangka dawa perusahaan|Utang jangka dawa Nyxoah SA NYXH|Utang jangka dawa perusahaan Microbot Medical Inc (MBOT)|Pro-Dex Inc. - Tanggungan utang jangka dawa perusahaan|Zentek Ltd. - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka dawa ELUT (elutia.com)|MLSS - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa NEXGEL Inc. NXGL|retractable.com (RVP) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Harvard Bioscience Inc.|FEMY (Femasys Inc.) - Utang jangka dawa perusahaan|Utang jangka dawa Predictive Oncology Corp POAI|Utang jangka dawa perusahaan CJMB|Gunggunge utang jangka dawa Atrion Corp.|Utang jangka dawa perusahaan NURO (NeuroMetrix Corp)